Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1.095 CHF
−451.26 M CHF
1.05 B CHF
89.55 M
About Sarepta Therapeutics, Inc.
Sector
CEO
Douglas S. Ingram
Headquarters
Cambridge
Website
Founded
1980
FIGI
BBG00LVGD035
Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
SRPT5657414
Sarepta Therapeutics, Inc. 1.25% 15-SEP-2027Yield to maturity
−2.72%
Maturity date
Sep 15, 2027
Explore more bonds
Curated watchlists where AB3A is featured.
Frequently Asked Questions
The current price of AB3A is 109.970 CHF — it has decreased by −15.40% in the past 24 hours. Watch SAREPTA THERA INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BX exchange SAREPTA THERA INC stocks are traded under the ticker AB3A.
AB3A stock has fallen by −15.40% compared to the previous week, the month change is a −15.40% fall, over the last year SAREPTA THERA INC has showed a 55.12% increase.
We've gathered analysts' opinions on SAREPTA THERA INC future price: according to them, AB3A price has a max estimate of 199.31 CHF and a min estimate of 68.26 CHF. Watch AB3A chart and read a more detailed SAREPTA THERA INC stock forecast: see what analysts think of SAREPTA THERA INC and suggest that you do with its stocks.
AB3A reached its all-time high on Jun 24, 2024 with the price of 145.362 CHF, and its all-time low was 67.382 CHF and was reached on Nov 1, 2023. View more price dynamics on AB3A chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
AB3A stock is 18.20% volatile and has beta coefficient of 1.45. Track SAREPTA THERA INC stock price on the chart and check out the list of the most volatile stocks — is SAREPTA THERA INC there?
Today SAREPTA THERA INC has the market capitalization of 10.99 B, it has decreased by −2.36% over the last week.
Yes, you can track SAREPTA THERA INC financials in yearly and quarterly reports right on TradingView.
SAREPTA THERA INC is going to release the next earnings report on Mar 4, 2025. Keep track of upcoming events with our Earnings Calendar.
AB3A earnings for the last quarter are 0.29 CHF per share, whereas the estimation was −0.05 CHF resulting in a 670.17% surprise. The estimated earnings for the next quarter are 1.45 CHF per share. See more details about SAREPTA THERA INC earnings.
SAREPTA THERA INC revenue for the last quarter amounts to 395.90 M CHF, despite the estimated figure of 345.05 M CHF. In the next quarter, revenue is expected to reach 534.57 M CHF.
AB3A net income for the last quarter is 28.48 M CHF, while the quarter before that showed 5.81 M CHF of net income which accounts for 390.43% change. Track more SAREPTA THERA INC financial stats to get the full picture.
No, AB3A doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jan 9, 2025, the company has 1.31 K employees. See our rating of the largest employees — is SAREPTA THERA INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SAREPTA THERA INC EBITDA is 115.09 M CHF, and current EBITDA margin is −16.80%. See more stats in SAREPTA THERA INC financial statements.
Like other stocks, AB3A shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SAREPTA THERA INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SAREPTA THERA INC technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SAREPTA THERA INC stock shows the strong sell signal. See more of SAREPTA THERA INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.